Semax Chemistry and ACTH Analog Mechanism

Semax is a heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) derived from ACTH(4-7)-PGP, an ACTH fragment with extended C-terminal pro-gly-pro dipeptide. The C-terminal Pro-Gly-Pro tripeptide extends the peptide's half-life (resistant to enzymatic degradation) and alters the receptor activation profile compared to native ACTH. Semax activates melanocortin receptors (primarily MC4R) in the brain rather than the adrenocortical ACTH receptor (MC2R), making Semax selective for neuronal effects without triggering cortisol production.

The heptapeptide structure (MW ~888 Da) is small enough to cross the blood-brain barrier (or penetrate brain tissue in ex vivo models) yet large enough to engage specific receptor selectivity. This selectivity is why Semax has been investigated as a neuroprotective research compound: BDNF induction without systemic glucocorticoid effects.

BDNF Upregulation Mechanism in Neural Cells

Semax treatment of primary cortical neurons, hippocampal neurons, and neural cell lines (SH-SY5Y, PC12) increases BDNF mRNA expression 1.5-3 fold as measured by qPCR. The mechanism involves MC4R activation → cAMP elevation → CREB (cAMP-responsive element binding protein) phosphorylation → CREB-mediated transactivation of the BDNF promoter (particularly BDNF exon I and IV promoters, which are CREB-responsive).

Downstream of BDNF synthesis, the peptide is released and can activate its cognate receptor TrkB (tropomyosin kinase B) on neurons in an autocrine or paracrine manner. TrkB activation leads to phosphorylation of downstream targets (Akt, ERK), supporting neuronal survival, synaptic plasticity, and mitochondrial homeostasis.

Neuroprotection Pathways and Cell Culture Models

Hypoxia models: Semax pre-treatment of cortical neurons exposed to hypoxia (1% O2) reduces neuronal apoptosis and maintains mitochondrial membrane potential. BDNF/TrkB signaling is hypothesized to support mitochondrial function during hypoxic stress.

Oxidative stress models: Semax pre-treatment of neurons exposed to H2O2 or rotenone (Complex I inhibitor) enhances survival and reduces ROS production. BDNF-mediated activation of Akt supports mitochondrial GSIS and glucose metabolism, improving ATP production under oxidative stress.

Excitotoxicity models: Semax protects neurons from NMDA or AMPA receptor overstimulation by enhancing BDNF-dependent survival signaling and reducing Ca2+ overload through CREB-dependent expression of calcium-buffering proteins.

Research Design: Cell Lines and Key Endpoints

Recommended cell models: Primary cortical or hippocampal neurons (highest BDNF responsiveness); SH-SY5Y neuroblastoma (human, widely available); PC12 cells (differentiated with NGF to enhance neuronal phenotype).

Key endpoints: (1) BDNF mRNA (qPCR); (2) BDNF protein (ELISA, Western blotting); (3) TrkB phosphorylation (pTrkB Tyr490 by Western); (4) Downstream kinases (pAkt Ser473, pERK1/2 Thr202/Tyr204); (5) Cell viability (MTS, LDH assay); (6) Mitochondrial function (membrane potential by TMRM, ATP content).

Concentration range: Published research uses Semax at 0.1-10 µM in cell culture. In vitro concentrations are substantially higher than likely CNS exposure in vivo (standard practice). Include a dose-response curve to characterize your specific cell type's response.

Semax vs. Selank Selectivity

Semax is ACTH-based and primarily acts through melanocortin receptors (MC4R) → BDNF upregulation. Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) is tuftsin-based and acts through enkephalin-degrading enzyme inhibition and GABAergic pathways. The two have distinct mechanisms and non-overlapping targets, making them complementary tools for studying different neuroprotection pathways.

Frequently Asked Questions

What is Semax and how does it differ from native ACTH?
Semax is a heptapeptide ACTH analog (Met-Glu-His-Phe-Pro-Gly-Pro) that activates melanocortin receptors in brain neurons (MC4R) rather than the adrenocortical ACTH receptor. This selectivity enables BDNF upregulation without cortisol production.
How does Semax upregulate BDNF?
Semax activates MC4R → cAMP elevation → CREB phosphorylation → CREB-mediated transactivation of BDNF promoters. Result: increased BDNF mRNA and protein synthesis in neurons.
What cell lines work best for Semax research?
Primary cortical or hippocampal neurons show the most robust BDNF responses. SH-SY5Y neuroblastoma and PC12 cells are widely available alternatives. PC12 cells should be differentiated with NGF to enhance neuronal phenotype.
What concentration should I use?
Published research typically uses 0.1-10 µM Semax in cell culture. Start with a dose-response curve (0.1, 1, 10 µM) to characterize your specific cell type. In vitro concentrations are much higher than in vivo levels (standard practice).
What are the key measurements for Semax experiments?
BDNF mRNA (qPCR), BDNF protein (ELISA), TrkB phosphorylation (Western), downstream Akt/ERK phosphorylation, cell viability (MTS), and mitochondrial function (ATP, membrane potential) for neuroprotection studies.

FOR RESEARCH USE ONLY. Not for human or animal consumption.